AR

Aarti Rohitash Maheshwari

Active Director Director DIN 09545278
DIN 09545278 First appointment Dec 2023 Primary industry Paper
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2023
Shareholding value •••• Premium profile

About Aarti Rohitash Maheshwari

Data last updated:

Aarti Rohitash Maheshwari is a Director at Apexio Pharma Private Limited (since 2023). The company operates in Paper. Apexio Pharma Private Limited reported revenue of ₹5.47 Cr (FY 2025).

DIN 09545278
Primary Designation Director
Industry Paper
First Appointment 26 Dec 2023
Oldest Company Age 2 yrs
Largest company Apexio Pharma Private Limited · ₹5.47 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Apexio Pharma Private Limited U21001MH2023PTC416041
Director26 Dec 20232023₹5.47 Cr (FY 2025)Active

Board colleagues of Aarti Rohitash Maheshwari

Directorship timeline

Open interactive timeline →
Apexio Pharma Private Limited
Premium access

Shareholding and investment profile for Aarti Rohitash Maheshwari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aarti Rohitash Maheshwari

Aarti Rohitash Maheshwari currently holds 1 directorship: Apexio Pharma Private Limited (Director, since 26 Dec 2023, revenue ₹5.47 Cr (FY 2025)).

Aarti Rohitash Maheshwari was first appointed on 26 Dec 2023 as Director at Apexio Pharma Private Limited.

The current boards of Aarti Rohitash Maheshwari's companies include Chenthanmara Kp Nair (Apexio Pharma Private Limited), Paresh Shantilal Bagadia (Apexio Pharma Private Limited), Payal Paresh Bagadia (Apexio Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available